Saniona A/S
Records under this name other than the patents Saniona A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,410,271 | Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,633,218 | 8-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,133,184 | Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,387,184 | Pharmaceutical compositions for combination therapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,696,350 | Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors Formerly held Term ended Term ended Jul 4, 2026 · From the USPTO record | Term ended | Term ended Jul 4, 2026 | From the USPTO record |
| US 8,697,721 | Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors Formerly held Lapsed on the fee record Ended Apr 15, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 15, 2026 | From the USPTO record |
| US 9,931,329 | Phenyl triazole derivative and its use for modulating the GABAA receptor complex Lapsed on the fee record Ended Apr 3, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 3, 2026 | From the USPTO record |
| US 9,884,848 | Phenyl triazole derivative and its use for modulating the GABAA receptor complex Lapsed on the fee record Ended Feb 6, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 6, 2026 | From the USPTO record |
| US 8,455,549 | Carbonylamino derivatives useful for the treatment of certain inflammatory disorders Lapsed on the fee record Ended Jun 4, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 4, 2025 | From the USPTO record |
| US 9,556,132 | Tetrazole derivatives and their use as potassium channel modulators Lapsed on the fee record Ended Jan 31, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 31, 2025 | From the USPTO record |